A technique to genetically modify a patient's own immune cells eradicated tumors in 14 of 16 patients with advanced leukemia—at least for a time—in a study that adds to growing enthusiasm for efforts to enlist the body's immune system in the fight against cancer.. The findings, from researchers at Memorial Sloan-Kettering Cancer Center, also add fuel to an emerging race to bring new so-called cancer immunotherapy treatments to the market. Juno Therapeutics Inc., a Seattle startup, is preparing to launch a mid-stage, or phase...
  